One of the prominent factors in inducing PD-L1 expression is the interferon-γ (IFN-γ) acting mainly via the JAK/STAT1/interferon regulatory factor (IRF) 1 pathway in multiple types of cancers (Ikeda et al., 2016; Moon et al., 2017). The gene discussed is IFNG; the disease is cancer.